Backflow Prevention Device Tester definition

Backflow Prevention Device Tester means an individual who is certified by the British Columbia Water and Waste Association and who is included in the District’s list of approved Testers of Backflow Prevention Devices;
Sample 1Sample 2Sample 3
Backflow Prevention Device Tester means a Person who has completed and passed a Cross Connection Control course in Backflow Prevention Device testing at an accredited school or college and shall be in accordance with CSA B64 10.1-01 Subsection 4. Device Testers and School Accreditation;
Sample 1

Examples of Backflow Prevention Device Tester in a sentence

  • Backflow Prevention Device Tester means an individual who is certified by the Department as a Massachusetts Backflow Prevention Device Tester.

  • Certified Backflow Prevention Device Tester means an individual who holds a valid Massachusetts Backflow Prevention Device Tester's Certificate issued by the Department.

  • Backflow prevention assemblies which are installed to provide protection against High Health Hazards must also be tested and certified to be operating within specifications at least annually by a Recognized Backflow Prevention Device Tester.

  • The District reserves the right to require the replacement or modification of any backflow prevention device that a certified Backflow Prevention Device Tester deems a potential hazard to the domestic water system.

  • These tests shall be performed by a certified Backflow Prevention Device Tester, and all test results and repairs shall be delivered to the Cambria Water District within seventy-two hours after test is made.

  • Ensuring that all backflow prevention device inspections are conducted by a Massachusetts Certified Backflow Prevention Device Tester and surveys for cross connections are conducted by a person who is certified by the Department as a Massachusetts Certified Cross Connection Surveyor.

  • For the purposes of this Agreement the term ‘information regarding individual financial institutions’ means information on individual financial institutions and information from which individual financial institutions can be identified.

  • As an interim arrangement to accommodate the transition to the FMSS system, Departments can calculate depreciation on a monthly or annual basis.

  • Currently, the European Union is actively involved in the search for a fifth own revenue source.

  • Any Certified Backflow Prevention Device Tester, Cross Connection Surveyor or person holding a valid Combination Certificate who desires to renew his or her certification must submit a renewal application including any renewal fee and prerequisites, no later than one month prior to the expiration date of his or her certificate.

Related to Backflow Prevention Device Tester

  • Backflow prevention device means a safety device used to prevent pollution or contamination of the water supply due to the reverse flow of water from the irrigation system.

  • Backflow Prevention Assembly means any mechanical assembly installed at a water service line or at a plumbing fixture to prevent a backflow contamination event, provided that the mechanical assembly is appropriate for the identified contaminant at the cross connection and is an in-line field-testable assembly.

  • Operational Acceptance Tests means the tests specified in the Technical Requirements and Agreed Project Plan to be carried out to ascertain whether the System, or a specified Sub system, is able to attain the functional and performance requirements specified in the Technical Requirements and Agreed Project Plan, in accordance with the provisions of GCC Clause 27.2 (Operational Acceptance Test).

  • Backflow preventer means a device or means to prevent backflow.

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • technical specification means, with respect to any Software, the document setting forth the technical specifications for such Software and included in the Statement of Work.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Acceptance Testing mean the tests, reviews and other activities that are performed by or on behalf of Agency to determine whether the Deliverables meet the Acceptance Criteria or otherwise satisfy the Agency, as determined by the Agency in its sole discretion.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Waste prevention means source reduction and reuse, but not recycling.

  • Air-purifying respirator means a respirator with an air-purifying filter, cartridge, or canister that removes specific air contaminants by passing ambient air through the air-purifying element.

  • Commissioning test means tests applied to the Generating Facility, after completion of the construction of the Generating Facility, in order to verify that the Generating Facility may be released for Operation.

  • Generation Interconnection Feasibility Study means a study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Tariff, Part IV, section 36.2.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Maintenance Test means the maintenance test set out in Clause 12.1 (Maintenance Test).

  • Acceptance Tests means those tests performed during the Performance Period which are intended to determine compliance of Equipment and Software with the specifications and all other Attachments incorporated herein by reference and to determine the reliability of the Equipment.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Technical Specifications means the detailed requirements for the Work furnished by the Architect and set forth in Book 3 of the Contract Documents.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Electrostatic application means the application to a substrate of charged atomized paint droplets that are deposited by electrostatic attraction.

  • Commissioning Tests means all of the procedures and tests which, in accordance with the Reasonable and Prudent Standard, and in compliance with industry guidelines, practices and standards, are:

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Stand-Alone Test Environment or "SATE" shall have the meaning set forth in Section 12.2.9.3.2.

  • Acceptance Test is a test of the Features executed by the Customer to prepare the acceptance.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).